Lava Therapeutics (NASDAQ: LVTX)
$1.32
(1.1%)
$0.02
Price as of June 23, 2025, 3:59 p.m. ET
Lava Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Lava Therapeutics Company Info
LAVA Therapeutics NV is an immuno-oncology company. It utilizes its proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.